您当前的位置：
首页 >
文章列表页 >
PD-L1 expression and smoke exposure as biomarkers for optimizing adjuvant therapy for patients with resected limited-stage small-cell lung carcinoma
更新时间：2023-08-29

    • PD-L1 expression and smoke exposure as biomarkers for optimizing adjuvant therapy for patients with resected limited-stage small-cell lung carcinoma

    • Genes & Diseases   Vol. 10, Issue 1, (2023)
    • 作者机构：

      1. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China,100021

      2. State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China,100021

      3. Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China,100021

    • DOI：10.1016/j.gendis.2022.02.017    

      CLC：

    • Published：2023，

      Published Online：1 January 2023，

    扫 描 看 全 文

  • Chengming Liu, Zhanyu Wang, Qingpeng Zeng, et al. PD-L1 expression and smoke exposure as biomarkers for optimizing adjuvant therapy for patients with resected limited-stage small-cell lung carcinoma. [J]. Genes & Diseases 10(1).(2023) DOI： 10.1016/j.gendis.2022.02.017.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0